Unique ID issued by UMIN | UMIN000009479 |
---|---|
Receipt number | R000011137 |
Scientific Title | A multicenter, randomized controlled study of the clinical efficacy of intravenous peramivir versus oseltamivir against influenza A and B virus infection in high-risk patients |
Date of disclosure of the study information | 2012/12/05 |
Last modified on | 2017/02/24 11:14:24 |
A multicenter, randomized controlled study of the clinical efficacy of intravenous peramivir versus oseltamivir against influenza A and B virus infection in high-risk patients
Comparative study of peramivir and
oseltamivir in the influenza virus
infection
A multicenter, randomized controlled study of the clinical efficacy of intravenous peramivir versus oseltamivir against influenza A and B virus infection in high-risk patients
Comparative study of peramivir and
oseltamivir in the influenza virus
infection
Japan |
Influenza virus infection
Medicine in general | Pneumology | Infectious disease |
Others
NO
Evaluation of clinical and viral effects of peramivir compared with oseltamivir in high-risk patients.
Safety,Efficacy
Not applicable
The duration of fever
Symptoms of influenza infection, viral titer and subtype, complications, exacerbation of underlying diseases, H275Y mutation of the virus isolated from the patients with poor clinical effects,
The detection of colonized pneumococcus in nasal pharynx in the patients complicated secondary bacterial pneumonia
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Medicine |
Peramivir,
Intravenously administration
600mg once a day, allowing daily injection if the patient condition is severe.
Oseltamivir,
Orally administration, 75mg twice a day for 5 days.
20 | years-old | <= |
Not applicable |
Male and Female
The patients who satisfied below 1)-7):
1)Age:>=20
2)Agreement with documents
3)Fever>=38.0 degrees centigrade
4)>=2 items of ISS* which as moderate symptoms
5)Within 48hour after onset:
Onset time is defined as below
(1)First time at increase of body temperature (>=1 degrees centigrade as usual)
(2)First time which the patient
aware >=1 items of ISS*
6)Positive for Rapid Antigen Test kit
7)With at least one risk factor
*ISS=Influenza Symptoms Severity
1)contraindication of peramivir and oseltamivir
2)pregnant or probable pregnant women
3)Inappropriate judged by doctors
4)pneumonia on the 1st day of visiting hospital
120
1st name | |
Middle name | |
Last name | Shigeki Nakamura |
Nagasaki University Hospital
Second Department of Internal Medicine
1-7-1, Sakamoto, Nagasaki city, Nagasaki prefecture.
095-819-7273
moju516@nagasaki-u.ac.jp
1st name | |
Middle name | |
Last name | Taiga Miyazaki |
Nagasaki evaluation organization for clinical interventions
office
1-7-1, Sakamoto, Nagasaki city, Nagasaki prefecture.
095-819-7273
shinkin@peath.co.jp
Nagasaki evaluation organization for clinical interventions
Nagasaki evaluation organization for clinical interventions
Non profit foundation
Japan
NO
・長崎大学病院(長崎県)
・日本赤十字社長崎原爆病院(長崎県)
・日本赤十字社長崎原爆諫早病院(長崎県)
・地方独立行政法人 北松中央病院(長崎県)
・佐世保市立総合病院(長崎県)
・独立行政法人国立病院機構 嬉野医療センター(佐賀県)
・長崎市立市民病院(長崎県)
・医療法人 光晴会病院(長崎県)
・医療法人 栄和会 泉川病院(長崎県)
・健康保険諫早総合病院(長崎県)
・千住診療所(長崎県)
・おにつか内科・消化器科(長崎県)
・医療法人 ともなが内科クリニック(長崎県)
・入船クリニック(長崎県)
・かわむら内科(長崎県)
・重野医院(長崎県)
2012 | Year | 12 | Month | 05 | Day |
Unpublished
Completed
2012 | Year | 11 | Month | 22 | Day |
2012 | Year | 11 | Month | 27 | Day |
2014 | Year | 06 | Month | 30 | Day |
2014 | Year | 08 | Month | 31 | Day |
2014 | Year | 10 | Month | 31 | Day |
2014 | Year | 12 | Month | 31 | Day |
2012 | Year | 12 | Month | 04 | Day |
2017 | Year | 02 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011137
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |